EIQ

ECHOIQLTD FPO [EIQ]
Echo IQ Limited, an artificial intelligence (AI) and medical technology company, engages in the development and application of AI for the cardiac diagnostics sector in Australia. It offers EchoSolv, a machine-learning and AI-based clinical decision support software for use as an adjunct to echocardiography in the assessment of severe aortic stenosis and other cardiovascular conditions. The company has a research collaboration with Mayo Clinic to assess cardiac risk in patients receiving cancer therapy. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is headquartered in Sydney, Australia.
Healthcare · ASX Small Cap
$1.2800 +0.0%

Updated 8 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-06
Get alerts when EIQ triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track EIQ — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Lagging the Small Ords index — relative strength of 0.79, underperforming its peers
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Trading above the 200-day average — the long-term trend is on your side
  • Low cash runway (3 quarters) - dilution risk
  • Very high P/S ratio (10305.7x)
  • EPS estimates revised upward (+10pts)
  • Sentiment is mixed — no strong consensus either way
  • Strong long-term momentum — up 710% over the past year (excluding last month)
  • Excellent risk-adjusted returns — Sharpe of 3.0 means strong gains without wild swings
  • The bigger volume days are the up days — volume-weighted momentum is positive (2.39%/day)
  • Altman Z-Score distress zone (1.77 < 1.81, low-confidence approx)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral

Expected next for EIQ

11 Oct 2026Quarterly Cash Flow Report (4C)Estimated from past filings
Window: 4 Oct to 18 Oct
The last 4 moved EIQ +3.9% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →

Recent Catalysts

NONE Investor Webinar
NONE EchoSolv HF FDA Application Update
NONE Pause in Trading
NEGATIVE Trading Halt

Recent ASX Announcements

2026-09-08 Investor Webinar
2026-09-08 EchoSolv HF FDA Application Update PRICE SENSITIVE
2026-09-07 Trading Halt PRICE SENSITIVE
2026-09-06 Pause in Trading PRICE SENSITIVE
2026-09-04 Notification of cessation of securities - EIQ

Key Metrics

$948.1M
Market Cap
2.8M
Avg Volume
1.0x
Vol Ratio
$0.17 — $1.88
52-Week Range
0.3%
Short Interest
N/A
Cash Runway
-108.0%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 76%
LLeader vs LaggardpassRS: 3
IInstitutional SponsorshipweakInst: 1%
MMarket DirectionneutralNeutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
PER -33.3%HIQ +20.0%OSL +17.0%LDX +15.0%ECS -14.3%
Compare:EIQ vs PEREIQ vs HIQEIQ vs OSL
Share this analysis

Track EIQ and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required